MedTrace Logo

Update of the EORTC QLQ-LC13 Quality of Life Questionnaire

NCT01434784 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 200

Last updated 2017-06-09

No results posted yet for this study

Summary

The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire Lung Cancer 13 (EORTC QLQ-LC13) is considered as a standard instrument to assess the quality of life (QL) of lung cancer patients. Since its publication in 1994, major clinical advances have been made. The research objective is to develop a revised lung cancer module that (a) covers all QL aspects relevant in the context of newly available diagnostic and therapeutic options, (b) is applicable in both non-metastatic and metastatic cancers, (c) and covers QL aspects that are generally relevant for patients with lung cancer but are missing in the original module. This project will comprise the first three project phases according to the Module Development Manual (www.eortc.be/qol).

Conditions

Sponsors & Collaborators

  • Hospital of Navarra

    collaborator OTHER

  • Oslo University Hospital

    collaborator OTHER

  • Medical University of Graz

    collaborator OTHER

  • University of Roma La Sapienza

    collaborator OTHER

  • National Taiwan University Hospital

    collaborator OTHER

  • University of Sydney

    collaborator OTHER

  • University of Wuerzburg

    collaborator OTHER

  • Michael Koller

    lead OTHER

Principal Investigators

  • Michael Koller, PhD · University Hospital Regensburg

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-09-30
Primary Completion
2015-01-31
Completion
2015-01-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01434784 on ClinicalTrials.gov